Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer.
By H. Martin, B. Campbell, C. Hart, C. Mpofu, M. Nayar, Ravinder Singh, H. Englyst, H. Williams, J. Rhodes. Gastroenterology, 2004
772 citations recorded by the source corpus.
Subfields: Food Science, Genetics, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/f45df9110bced2f6e9dea134488c4305ee969fbd
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Food Science
In Genetics
In Molecular Biology
- M. Zeng
- G. Núñez
- Xiaoyan Pang
- Menghui Zhang
- Liping Zhao
- N. Fei
- Patrice D Cani
- Sivaraman Balakrishnan
Citations in the corpus
- Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin (2013, background): “It is often difficult to distinguish the roles of adherence and invasion as these two processes are tightly correlated (Martin et al., 2004; Swidsinski et al., 1998), with the former being a prerequisite for the latter.”
- Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum (2007, methodology): “coli have been associated with Crohn’s colitis and colonic cancer (Martin et al., 2004), and E.”
- Intestinal inflammation targets cancer-inducing activity of the microbiota (2012, background): “coli strains isolated from colorectal tissue specimens of 35 patients with IBD, 21 with CRC, and 24 non-IBD/non-CRC controls (11).”
- Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers (2011, background): “(Martin et al., 2004) have found increased proportion of hemagglutinin expressing Escherichia coli in Crohn’s disease and colon cancer patients compared with healthy controls.”
- Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome (2019, neutral): “coli and non-jejuni Campylobacter) Increase [147,148]”
- Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease (2017, background): “coli has been described in patients with CD (139, 140).”